Innovator IBD Breakout Opportunities ETF Rating $38.66 +0.12 (+0.30%) As of 03:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Innovator IBD Breakout Opportunities ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BOUT Aggregate RatingModerate Buy 2.74Holdings in BOUT have an aggregate rating of Moderate Buy based on 319 analyst ratings issued in the past year covering 23 companies (72.5% of the portfolio).BOUT Aggregate Price Target$38.66High Prediction$38.66Average Prediction$38.66Low Prediction$38.66Holdings in BOUT have an aggregate price target of $38.66 and a range of $38.66 to $38.66 covering 23 companies (72.5% of the portfolio).BOUT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell1 Strong Sell rating(s) Ratings for Stocks Held by Innovator IBD Breakout Opportunities ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 BOUT Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.95%MDGLMadrigal Pharmaceuticals$427.75-1.0%4.289 of 5 stars2.90$483.38 13.0%10Analyst Forecast3.87%SRADSportradar Group$30.13-0.7%3.0084 of 5 stars2.84$31.41 4.3%19Analyst Forecast3.86%UMBFUMB Financial$120.17-0.4%4.9121 of 5 stars2.78$133.89 11.4%9Positive News3.83%APPAppLovin$590.56+1.5%2.6702 of 5 stars2.88$501.95 -15.0%24Analyst Forecast3.76%SCHWCharles Schwab$91.95-1.7%4.8481 of 5 stars2.67$99.60 8.3%21Positive News3.70%GOOGLAlphabet$250.62+4.1%3.8901 of 5 stars2.84$222.85 -11.1%45Trending NewsAnalyst Upgrade3.70%MTZMasTec$192.96+1.7%3.5856 of 5 stars3.10$196.22 1.7%20Positive NewsAnalyst Downgrade3.59%MWAMueller Water Products$25.24+0.8%4.6457 of 5 stars2.33$28.33 12.3%3Positive News3.50%THCTenet Healthcare$187.54-2.7%4.6997 of 5 stars2.84$195.50 4.2%19Insider Trade3.42%ATGEAdtalem Global Education$134.56-2.0%4.5219 of 5 stars2.75$139.00 3.3%4Positive News3.41%SKYWSkyWest$104.88-2.6%4.4937 of 5 stars3.00$126.75 20.9%4Positive News3.28%GVAGranite Construction$109.28+1.7%1.315 of 5 stars1.00$76.00 -30.5%1Positive NewsDividend Announcement3.23%COFCapital One Financial$226.95+1.4%4.967 of 5 stars2.95$239.44 5.5%20News CoveragePositive NewsAnalyst Forecast3.23%KTOSKratos Defense & Security Solutions$70.81+2.3%2.4409 of 5 stars2.94$57.64 -18.6%16News CoveragePositive News3.21%APGAPi Group$35.25+1.0%2.9481 of 5 stars3.00$36.10 2.4%8Positive News3.18%ENVAEnova International$116.19+0.9%2.1814 of 5 stars3.17$111.00 -4.5%62.33%LIFLife360$102.58+2.3%1.0915 of 5 stars3.00$86.43 -15.7%72.28%AMZNAmazon.com$231.17+1.3%4.8467 of 5 stars3.00$262.87 13.7%50Trending News2.24%YMMFull Truck Alliance$13.58-0.3%3.294 of 5 stars2.80$15.00 10.5%5Positive News2.23%LRNStride$137.12-13.4%3.3162 of 5 stars2.67$146.40 6.8%6News CoveragePositive NewsHigh Trading Volume2.23%MODModine Manufacturing$152.58+1.9%2.5373 of 5 stars3.00$145.67 -4.5%32.22%INCYIncyte$83.20+0.1%4.7434 of 5 stars2.33$82.53 -0.8%18Positive NewsAnalyst DowngradeShort Interest ↓2.20%NBNNortheast Bancorp$109.79-0.6%3.0598 of 5 stars2.00$115.00 4.7%1News CoveragePositive News This page (NYSEARCA:BOUT) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD Breakout Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD Breakout Opportunities ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BOUT Stock Alerts